Skip to main content
SpringerLink
Log in

Effect of hypoglycaemia, TRH and levodopa on plasma growth hormone, prolactin, thyrotropin and cortisol in Parkinson's disease before and during therapy

  • Original Investigations
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Summary

Thirteen drug-free and not severely affected patients with idiopathic Parkinson's disease underwent an insulin-hypoglycaemia test, a TRH test and a levodopa test. The responses of growth hormone, prolactin, cortisol and thyrotropin were measured, and retested under stable therapy with levodopa and benserazide. Mean basal and stimulated hormonal concentrations were in the normal range before and during therapy. Minor abnormalities were observed in individual cases, but did not indicate a hypothalamic dopamine deficit.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Agnoli A, Baldassarre M, Ruggieri S, Falaschi P, Urso RD, Rocco A (1981) Prolactin response as an index of dopaminergic receptor function in Parkinson's disease. J Neural Transm 52:123–134

    Google Scholar 

  2. Bernheimer H, Birkmayer W, Hornykiewicz O (1963) Zur Biochemie des Parkinson-Syndroms des Menschen. Klin Wochenschr 410:465–469

    Google Scholar 

  3. Birkmayer W, Danielczyk W, Neumayer E, Riederer P (1974) Nucleus ruber and L-dopa-psychosis. Biochemical post mortem findings. J Neural Transm 35:93–116

    Google Scholar 

  4. Blichert-Toft M (1975) Corticotrophin secretion in old age. Acta Endocrinol [Suppl 195] 78:1–155

    Google Scholar 

  5. Boyd AE, Lebovitz HE, Pfeiffer JB (1970) Stimulation of human-growth-hormone secretion by L-dopa. N Engl J Med 283:1425–1429

    Google Scholar 

  6. Brambilla F, Smeraldi E, Bellodi L, Saccetti E, Müller EE (1980) Neuroendocrine correlates and monoaminergic hypothesis in primary affective disorders. In: Brambilla F, Racagni G, deWied D (eds) Progress in psychoneuroendocrinology. Elsevier, Amsterdam New York Oxford, pp 235–245

    Google Scholar 

  7. Burrow GN, Spaulding SW, Donabedian R, Woert MV, Ambani L (1974) The effect of L-dopa on the hypothalamic-pituitary-thyroid axis. Adv Neurol 5:489–493

    Google Scholar 

  8. Cavagnini F, Peracchi M, Scotti G, Raggi U, Pontirolli AE, Bana R (1972) Effect of L-dopa administration on growth hormone secretion in normal subjects and Parkinsonian patients. J Endocrinol 54:425–433

    Google Scholar 

  9. Debono AG, Donaldson I, Marsden CD, Parkes JD (1975) Bromocriptine in Parkinsonism. Lancet II:987–988

    Google Scholar 

  10. Dudl RJ, Ensinck JW, Palmer HE, Williams RH (1973) Effect of age on growth hormone secretion in man. J Clin Endocrinol Metab 37:11–16

    Google Scholar 

  11. Eddy RL, Gilliland PF, Ibarra JD, McMurry JF, Thompson JO (1974) Human growth hormone release. Am J Med 56:179–185

    Google Scholar 

  12. Ehringer H, Hornykiewicz O (1960) Verteilung von Noradrenalin und Dopamin im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems. Wien Klin Wochenschr 72:1236–1239

    Google Scholar 

  13. Eisler T, Thorner MO, McLeod RM, Kaiser DL, Calne DB (1981) Prolactin secretion in Parkinson disease. Neurology (NY) 31:1356–1359

    Google Scholar 

  14. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology (Minneap) 17:427–442

    Google Scholar 

  15. Hyyppä MT, Loangvik VA, Rinne UK (1978) Plasma pituitary hormones in patients with Parkinson's disease treated with bromocriptine. J Neural Transm 42:151–157

    Google Scholar 

  16. Jacob H (1983) Klinische Neuropathologie des Parkinsonismus. In: Pathophysiologie, Klinik und Therapie des Parkinsonismus. 13. Zentraleuropäisches Neurologisches Symposion. Editiones Roche, Basel, pp 5–18

    Google Scholar 

  17. Lancranjan I, Pozo ED, Ohnhaus E (1978) Inhibitory effect of guanfacine, a central alpha-adrenoceptor agonist on prolactin secretion stimulated by insulin-induced hypoglycemia. J Clin Endocrinol Metab 47:671–674

    Google Scholar 

  18. Langston JW, Forno LS (1978) The hypothalamus in Parkinsons disease. Ann Neurol 3:129–133

    Google Scholar 

  19. Lavin PJ, Gawel MJ, Das PK, Alaghband-Zadeh J, Rose FC (1981) Effect of levodopa on thyroid function and prolactin release. A study in patients with Parkinson's disease. Arch Neurol 38:759–760

    Google Scholar 

  20. Leebaw WF, Lee LA, Woolf PD (1978) Dopamine affects basal and augmented pituitary hormone secretion. J Clin Endocrinol Metab 47:480–487

    Google Scholar 

  21. Leebaw WF, Lee LA, Woolf PD (1978) The effects of the dopamine agonist, lergotrile mesylate, on prolactin secretion in women. Acta Endocrinol 87:12–18

    Google Scholar 

  22. Linnoila M, Lamberg BA, Rosberg G, Karonen SL, Welin MG (1979) Thyroid hormones and TSH, prolactin and LH response to repeated TRH and LRH injections in depressed patients. Acta Psychiatr Scand 59:536–544

    Google Scholar 

  23. Loosen PT, Prange AJ (1980) Thyrotropin releasing hormone (TRH) — a useful tool for psychoneuroendocrine investigation. Psychoneuroendocrinology 5:63–80

    Google Scholar 

  24. Lundberg PO (1972) Blood levels of FSH, LH, TSH, and GH in Parkinsonian patients before and during L-dopa treatment. Acta Neurol Scand 48:427–432

    Google Scholar 

  25. Malarley WB, Cyrus J, Paulson GW (1974) Dissociation of growth hormone and prolactin secretion in Parkinson's disease following chronic L-dopa therapy. J Clin Endocrinol Metab 39:229–235

    Google Scholar 

  26. Martinez-Campos A, Giovannini P, Novelli A, Cocci D, Caraceni T, Müller EE (1982) Thyrotropin and prolactin responses to thyrotrophin-releasing hormone in patients with Parkinson's disease. Acta Endocrinol 99:344–351

    Google Scholar 

  27. Masala A, Delitala G, Alagna S, Devilla L (1977) Effect of pimozide on levodopa-induced growth hormone release in man. Clin Endocrinol 7:253–256

    Google Scholar 

  28. Masala A, Delitala G, Devilla L, Alagna S, Rovasio PP (1979) Enhancement of insulin-induced prolactin secretion by fluoxetine in man. J Clin Endocrinol Metab 49:350–352

    Google Scholar 

  29. Nathan RS, Sachar EJ, Tabrizi MA, Halbreich U, Asnis GM, Halpern FS (1981) Effect of metergoline on the diurnal prolactine response of insulin-induced hypoglycemia in normal men. Psychoneuroendocrinology 6:365–368

    Google Scholar 

  30. Nathan RS, Sachar EJ, Ostrow L, Asnis GM, Halbreich U, Halpern FS (1981) Failure of dopaminergic blockade to affect prolactin, growth hormone, and cortisol response to insulin-induced hypoglycemia in schizophrenics. J Clin Endocrinol Metab 52:807–809

    Google Scholar 

  31. Noel GL, Suh HK, Frantz AG (1973) L-Dopa suppression of TRH-stimulated prolactin release in man. J Clin Endocrinol Metab 36:1255–1258

    Google Scholar 

  32. Polleri A, Carolei A, Rolandi E, Masturzo P, Meco G, Agnoli A (1977) Changes in pituitary hormone serum levels in bromocriptine-treated Parkinsonian patients. Neuropsychobiology 3:42–48

    Google Scholar 

  33. Quabbe HJ (1969) Radioimmunologische Bestimmung von Wachstumshormon im Plasma des Menschen. J Clin Chem Clin Biochem 7:259–263

    Google Scholar 

  34. Riederer P, Wuketich S (1976) Time-course of nigrostriatal degeneration in Parkinson's disease. J Neural Transm 38:377–382

    Google Scholar 

  35. Rolandi E, Magnani G, Sannia A, Barreca T (1982) Evaluation of PRL secretion in elderly subjects. Acta Endocrinol 100:351–357

    Google Scholar 

  36. Rosak C, Vogel D, Althoff PH, Neubauer M, Brecht HM, Schiffling H (1982) Hormonal and metabolic parameters following insulin induced hypoglycemia. Endokrinologie 79:337–344

    Google Scholar 

  37. Sachar EJ, Mushrush G, Perlow M, Weitzman ED, Sassin J (1972) Growth hormone response to L-dopa in depressed patients. Science 178:1304–1305

    Google Scholar 

  38. Saito S, Abe K, Nagata N, Nakamura E, Tanaka K (1972) Effect of L-dopa on anterior pituitary hormone release in man. Endocrinol Jpn 19:435–442

    Google Scholar 

  39. Shaw KM, Lees AJ, Franks S, Daggett P, Thompson BD, Stern GM (1978) Endocrine aspects of bromocriptine therapy in Parkinsonism. J Neural Transm 43:153–160

    Google Scholar 

  40. Sirtori CR, Bolme P, Azarnoff DL (1972) Metabolic responses to acute and chronic L-dopa administration in patients with Parkinsonism. N Engl J Med 287:729–733

    Google Scholar 

  41. Snyder PJ, Utiger RD (1972) Response to TRH in normal men. J Clin Endocrinol Metab 34:380–385

    Google Scholar 

  42. Spaulding SW, Burrow GN, Donabedian R, Woert MV (1972) L-Dopa suppression of thyrotropin releasing hormone response in man. J Clin Endocrinol Metab 35:182–185

    Google Scholar 

  43. Viberti G, Tognetti A, Pontiroli AE, Marigo S, Mignani E, Pozza G (1974) Effect of ageing on insulin and growth hormone response to glucose and arginine in normal subjects. Acta Diabetol Lat 11:432–436

    Google Scholar 

  44. Werder K v, Loon RV, Yatsu F, Forsham PH (1970) Corticosteroid and growth hormone secretion in patients treated with L-dopa. Klin Wochenschr 48:1454–1456

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Klinikum Steglitz, Free University of Berlin, Hindenburgdamm 30, D-1000, Berlin 45

    H. P. Vogel & R. Ketsche

Authors
  1. H. P. Vogel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Ketsche
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vogel, H.P., Ketsche, R. Effect of hypoglycaemia, TRH and levodopa on plasma growth hormone, prolactin, thyrotropin and cortisol in Parkinson's disease before and during therapy. J Neurol 233, 149–152 (1986). https://doi.org/10.1007/BF00314421

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00314421

Key words

Search

Navigation